The Philadelphia Eagles’ management of quarterback Jalen Hurts’s blood clots received support from the NFL, while the players’ union later called for an investigation into the matter. The Eagles were confirmed to not face disciplinary action regarding their handling of Hurts, according to a knowledgeable source. Dr. Allen Sills, the NFL’s chief medical officer, defended the Eagles’ approach to treating Hurts, emphasizing the team’s caution and patient-centered care.
The NFL stated that they maintained communication with the Eagles’ medical staff and the Cleveland Clinic in London throughout the process. Sills expressed confidence in the Eagles’ medical team, praising their conservative and vigilant actions. The NFL Players Association requested a full investigation into the situation to ensure optimal care for players in the future.
Hurts, who is on injured reserve, is expected to miss the remainder of the season due to a blood clot in his left calf that traveled to his lungs. The NFL refuted reports of Hurts going without sleep before playing, clarifying that he had sufficient rest. Sills emphasized the importance of privacy in medical matters and highlighted the complexity of treating blood clots.
Vascular surgeon Dr. Caron Rockman supported the Eagles’ actions, noting the nuanced nature of dealing with such medical issues. Hurts’s ongoing treatment involves blood thinners, restricting his participation in football activities. The league and medical experts emphasized the prioritization of players’ health over athletic performance in medical decision-making.
